However, it is not clear whether adiponectin is protective against these metabolic disorders or whether these associations are just reflecting reverse causality (where disease status could alter adiponectin concentration) or residual confounding (where adiponectin could be a marker of another causal factor, such as adiposity or insulin resistance). Here, ADIPOQ is linked to metabolic disease.